Orum Therapeutics, Inc. (KOSDAQ:475830)
109,000
-8,300 (-7.08%)
At close: Feb 6, 2026
419.05% (1Y)
| Market Cap | 2.31T |
| Revenue (ttm) | 25.48M -100.0% |
| Net Income | -36.88B |
| EPS | -2,048.17 |
| Shares Out | 21.23M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 189,946 |
| Average Volume | 437,905 |
| Open | 109,100 |
| Previous Close | 117,300 |
| Day's Range | 106,100 - 113,000 |
| 52-Week Range | 15,950 - 146,600 |
| Beta | n/a |
| RSI | 47.57 |
| Earnings Date | Mar 20, 2026 |